Researchers Continue Trials On Vitamin A-Fortified Rice Strain

The Wall Street Journal examines golden rice, a new strain of vitamin A-fortified rice developed by researchers at the International Rice Research Institute meant to address deficiencies of the micronutrient among children. “A lack of the vitamin is a leading cause of preventable blindness and is linked to death due to infections in many poor countries,” the newspaper writes. “The golden rice program has received the backing of such groups as the Bill & Melinda Gates Foundation, Helen Keller International, the Rockefeller Foundation and [USAID],” which “provided $10.3 million in 2010 that is paying for research on golden rice’s safety and field trials in the Philippines and Bangladesh,” the newspaper notes. However, “opponents, such as Greenpeace International, … war[n] that genetically modified organisms could unleash serious, long-lasting problems in the environment,” according to the Wall Street Journal. The newspaper summarizes clinical trial results on the rice and includes comments from several experts (Larano, 9/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.